TuHURA Biosciences adopted a 2026 inducement Equity plan reserving 5,000,000 common shares for awards to eligible new employees. The plan matters to investors because it is intended to attract individuals to employment through equity-based and cash incentive awards, while allowing qualifying grants without stockholder approval under Nasdaq Listing Rule 5635.
Key Highlights
- The plan is intended for equity awards that induce eligible individuals to join TuHURA Biosciences or its subsidiaries.
- TuHURA adopted the plan without stockholder approval under Nasdaq Listing Rule 5635.
- TuHURA Biosciences reserved 5,000,000 common shares under the 2026 inducement equity incentive plan.
TuHURA Biosciences, Inc. (NASDAQ: HURA) adopted a 2026 inducement equity incentive plan that reserves 5,000,000 shares of common stock for potential awards. The plan is intended to help attract new employees to TuHURA Biosciences or its subsidiaries through equity-based and cash incentives. Qualifying grants can be made without stockholder approval under Nasdaq Listing Rule 5635. The Board adopted the plan on sep 10, 2026.
5M Shares Reserved for Employee Awards
Its reserved securities are common stock with a Par Value of $0.001 per share. Incentive stock Options are excluded. The Compensation Committee administers the plan. Awards may be approved by that committee when it consists only of independent directors, or by a majority of TuHURA Biosciences’ independent directors. Awards issued under other equity compensation plans remain subject to those plans and their existing award agreements.
FAQs
Q: How many shares did TuHURA Biosciences reserve under its 2026 inducement plan?
A: TuHURA Biosciences reserved 5,000,000 common shares under the 2026 inducement equity incentive plan. The shares carry a par value of $0.001 each.
Q: Can TuHURA Biosciences grant awards without stockholder approval?
A: Yes. The plan permits qualifying inducement awards without stockholder approval under Nasdaq Listing Rule 5635.
Q: Who can receive awards under the TuHURA inducement plan?
A: Awards are limited to individuals who satisfy the Nasdaq standard for inducement grants. The plan is intended to support employment with TuHURA Biosciences or one of its subsidiaries.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.